Delivery Order SPE2DB24D2205-SPE2DB24FDTGN
Award Date
4/29/24
Potential Completion Date
4/30/24
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,874.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II Vaccine Vials, a vaccine used for the prevention of measles, mumps, and rubella. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999...
This federal contract award, valued at $10,061.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials. It is a firm-fixed-price delivery order with a completion date of February 3, 2025. The contract was not set aside for any specific business category. In addition to this contract, AmerisourceBergen holds a...
This federal contract award is for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $1,024.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024 with a completion date of June 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $11,356.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of August 20, 2024. The contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office Division, has been awarded various federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (Measles, Mumps, and Rubella) vaccine vials. The contract has a ceiling value of $10,496.40 and a completion date of September 20, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA). The $1,661.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 24, 2025 with an ultimate completion date of February 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $5,123.90, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of measles, mumps, and rubella (MMR) vaccines and is a firm fixed-price Delivery Order that runs through April 16, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The order is for 4,565,350 units of the M-M-R II vaccine, a critical medical product used to prevent measles, mumps, and rubella. The fixed-price contract has a ceiling value of $14,081.38 and an ultimate completion date of August 6, 2024. This award is not associated with any set-aside program. Amerisourcebergen, as a...
This federal contract award is for the delivery of M-M-R II (Measles-Mumps-Rubella) vaccine vials to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,024.76 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The $22,723.12 firm-fixed-price contract has an ultimate completion date of August 29, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the efficient procurement of...